RECKITT BENCKISER GROUP
PLC
DIRECTORATE
CHANGE
Reckitt announces the
appointment of
Mahesh Madhavan and Stefan
Oschmann as Non-Executive Directors
Reckitt Benckiser Group plc (the
"Company" or "Reckitt") today announces the
appointment of Mahesh Madhavan, current CEO of Bacardi and Stefan
Oschmann, former CEO of Merck KGaA, to the Board as Non-Executive
Directors, effective 1 January 2025.
Mahesh is CEO of Bacardi Ltd having
joined in 1997 and held a number of regional leadership roles
before being promoted to CEO in 2017. Since becoming CEO he has led
a successful transformation of the business, providing stability
and a clear strategy for success to the organisation. Previously,
Mahesh held various roles at International Distillers &
Vintners, FCB Ulka Advertising and Wipro Consumer
products.
Mahesh is currently a Non-Executive
Director of Capri Holdings.
Mahesh will join the Remuneration
Committee from February 2025.
Stefan Oschmann is the former CEO
and Chair of Merck KGaA which he joined in 2011 as a member of the
Executive Board and CEO of Merck Biopharma and held a number of
senior leadership roles within the healthcare business before
becoming CEO and Chair of Merck between 2016 and 2021. Prior to
that Stefan spent 30 years at Merck & Co in various leadership
roles. Stefan brings strong transformational experience in science,
healthcare and technology.
Stefan is currently a Non-Executive
Director at Stamm, European Healthcare Acquisition & Growth,
Springer Nature and is Chair of AiCuris Anti-Infective
Cures.
Stefan will join the Compliance
Committee from February 2025.
Commenting on the appointment, Sir
Jeremy Darroch, Chair of the Board said:
"I am delighted that Mahesh and
Stefan have agreed to join the Reckitt Board. They are both
outstanding leaders, with many years' experience as CEO's of large
global businesses. We welcome the value and expertise both will bring to
the Board."
The Company confirms that there is
no further information to be disclosed under the requirements of
Listing Rule 9.6.13R in relation to the appointments.
Contact Details:
Catheryn O'Rourke
+44 (0) 1753 217 800
General Counsel & Company
Secretary
Nick
Ashworth
+44 (0) 7408 812350
Investor Relations
About Reckitt:
Reckitt* exists to protect, heal and
nurture in the relentless pursuit of a cleaner, healthier world. We
believe that access to the highest-quality hygiene, wellness and
nourishment is a right, not a privilege.
Reckitt is the company behind some
of the world's most recognisable and trusted consumer brands in
hygiene, health and nutrition, including Air Wick, Calgon, Cillit
Bang, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol,
Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet,
Woolite and more.
Every day, more than 20 million
Reckitt products are bought globally. We always put consumers and
people first, seek out new opportunities, strive for excellence in
all that we do and build shared success with all our partners. We
aim to do the right thing, always.
We are a diverse global team of c.
40,000 colleagues. We draw on our collective energy to meet our
ambitions of purpose-led brands, a healthier planet and a fairer
society. Find out more, or get in touch with us
at www.reckitt.com
* Reckitt is the trading name of the
Reckitt Benckiser group of companies
Reckitt Benckiser Group plc's LEI
code is 5493003JFSMOJG48V108
